# Menadione Topical Lotion in Treating Skin Discomfort and Psychological Distress in Patients With Cancer Receiving Panitumumab, Erlotinib Hydrochloride, or Cetuximab

> **NCT01393821** · NA · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 27 (actual)

## Conditions studied

- Dermatologic Complications
- Malignant Neoplasm
- Pain

## Interventions

- **DRUG:** menadione topical lotion
- **OTHER:** placebo
- **OTHER:** questionnaire administration
- **PROCEDURE:** management of therapy complications

## Key facts

- **NCT ID:** NCT01393821
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01-23
- **Primary completion:** 2013-05-11
- **Final completion:** 2018-07-14
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2025-05-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01393821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01393821, "Menadione Topical Lotion in Treating Skin Discomfort and Psychological Distress in Patients With Cancer Receiving Panitumumab, Erlotinib Hydrochloride, or Cetuximab". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT01393821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*